Quantcast

Latest HIV vaccine Stories

2014-08-01 08:26:14

PLYMOUTH MEETING, Pa., Aug. 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that it will host a conference call to report its second quarter 2014 financial results on Monday, August 11, 2014 at 9:00 AM ET. CEO Dr. J. Joseph Kim and CFO Peter Kies will discuss second quarter earnings, provide a corporate update, and participate in a live Q&A with analysts. The update will include clinical development plans for VGX-3100, Inovio's immune therapy...

2014-07-23 12:31:13

MELBOURNE, Australia, July 23, 2014 /CNW/ - The Honourable Rona Ambrose, Minister of Health, participated in the 20(th) International AIDS Conference this week in Melbourne, Australia. During the Conference sessions, meetings and side events, Minister Ambrose reinforced Canada's continued commitment to global efforts to address HIV/AIDS and to advancing a comprehensive and integrated long-term approach to address HIV/AIDS in Canada. While in Melbourne, Minister Ambrose toured the...

2014-07-01 04:21:59

Inovio Shares Enter No. 1 U.S. Equity Index for Asset Benchmarking PLYMOUTH MEETING, Pa., July 1, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced that it has been added to the Russell Global, Russell 2000 and Russell Microcap Indexes. Each June, Russell realigns its family of global equity indexes to reflect market changes in the past year. Approximately $5.2 trillion in assets are currently benchmarked to Russell Indexes. Many investors use mutual funds...

2014-06-24 10:58:46

Monash University Huge advancements have taken place in HIV treatment and prevention over the past 10 years, but there is still no cure or vaccine. The findings are part of a review into the global HIV epidemic published in The Lancet, co-authored by Monash University Professor Sharon Lewin. The review shows that because of advancements in treatment, people with the virus are living longer. Overall, new infections have decreased from 3.3 million in 2002 to 2.3 million in 2012....

2014-06-18 16:26:28

Breaking New Ground in a Collective Search for Vaccines against Major Killer Diseases NEW YORK, June 18, 2014 /PRNewswire-USNewswire/ -- New technologies and insights in antigen discovery, genomics and immunological monitoring offer tremendous potential that could be collectively leveraged to speed development of vaccines against major diseases, according to leading scientists who met across specializations to explore creation of a Human Vaccines Project and reported their...

2014-06-16 04:21:37

BLUE BELL, Pa., June 16, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President & CEO, Dr. J. Joseph Kim, will participate in a panel at the Piper Jaffray GenomeRx Symposium on June 23 to discuss Inovio's leadership in the advancement of novel DNA-based immune therapies. Inovio management will also present a corporate overview at the 2014 BIO International Convention hosted by the Biotechnology Industry Organization (BIO). This year's...

2014-05-30 04:22:21

BLUE BELL, Pa., May 30, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its previously announced 1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014. The common stock will continue to trade under the symbol "INO." As filed on May 22, 2014, the Company's stockholders approved the proposal of a reverse...

2014-05-29 16:26:48

WASHINGTON, May 29, 2014 /PRNewswire-USNewswire/ -- The PATH Malaria Vaccine Initiative (MVI) announced today that C. Richter (Rick) King, PhD, has been named Director of Research & Development (R&D). MVI drives the development of safe and effective vaccines to combat malaria. Malaria still kills more than 600,000 people worldwide, and half the world's population remains at risk of contracting the disease. Dr. King is an accomplished scientist with more than 25 years of...

2014-05-27 04:21:46

BLUE BELL, Pa., May 27, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced that its 90%-owned subsidiary, VGX Animal Health, Inc. (VAH), has concluded an agreement for the sale of its animal health assets to Plumbline Life Sciences, Inc. (PLS) of Korea. The assets being transferred include an exclusive license with Inovio for animal applications of its growth hormone-releasing hormone (GHRH) technology and animal DNA vaccines plus a non-exclusive license...

2014-05-27 04:21:43

Protection Data Presented at the 17th Annual Meeting of the American Society of Gene & Cell Therapy BLUE BELL, Pa., May 27, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that its novel DNA-based therapeutic monoclonal antibody targeting Chikungunya virus (CHIKV) completely protected mice from a lethal CHIKV challenge. In this preclinical study, a prototype DNA plasmid construct encoding for a monoclonal antibody for CHIKV envelope protein was...


Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related